mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.004 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.005 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.005 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.005 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.006 |